| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.08 | 0.6 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.073 | 0.7 |